Kölmel, K F <br/><br/>
Prior immunisation of patients with malignant melanoma with vaccinia or BCG is associated with better survival. An European Organization for Research and Treatment of Cancer cohort study on 542 patients.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Jan 2005 
 - 118-25 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2004.09.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>BCG Vaccine--immunology<br/>Cohort Studies<br/>Female<br/>Humans<br/>Immunization<br/>Male<br/>Melanoma--immunology<br/>Middle Aged<br/>Prognosis<br/>Skin Neoplasms--immunology<br/>Smallpox Vaccine--immunology<br/>Survival Analysis<br/>Vaccination<br/>Vaccinia--immunology